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Abstract
Background: Cation	transport	regulator	1	(CHAC1),	a	newly	discovered	enzyme	that	de‐
grades glutathione, is induced in Helicobacter pylori (H. pylori)‐infected	gastric	epithelial	
cells	in	culture.	The	CHAC1‐induced	decrease	in	glutathione	leads	to	an	accumulation	
of reactive oxygen species and somatic mutations in TP53. We evaluated the possible 
correlation between H. pylori	infection	and	CHAC1	expression	in	human	gastric	mucosa.
Materials and Methods: Both	fresh‐frozen	and	formalin‐fixed	paraffin‐embedded	tis‐
sue samples of gastric mucosa with or without H. pylori infection were obtained from 
41 esophageal cancer patients that underwent esophago‐gastrectomy. Fresh sam‐
ples were used for real‐time polymerase chain reaction for H. pylori	DNA	and	CHAC1	
mRNA,	and	 formalin‐fixed	 samples	were	used	 for	 immunohistochemistry	with	anti‐
CHAC1	and	anti‐H. pylori	monoclonal	antibodies.	Double‐enzyme	or	fluorescence	im‐
munohistochemistry and immuno‐electron microscopy were used for further analysis.
Results: Significant	CHAC1	overexpression	was	detected	in	H. pylori‐infected parietal 
cells	that	expressed	the	human	proton	pump/H,K‐ATPase	α subunit, whereas a con‐
stitutively	low	level	of	CHAC1	mRNA	expression	was	observed	in	the	other	samples	
regardless of the H. pylori	 infection	status,	 reflecting	 the	weak	CHAC1	expression	
detected by immunohistochemistry in the fundic‐gland areas. Immuno‐electron mi‐
croscopy revealed intact H. pylori cells in the secretory canaliculi of infected parietal 
cells.	Some	parietal	cells	exhibited	positive	nuclear	signals	for	Ki67	in	the	neck	zone	
of the gastric fundic‐gland mucosa with H. pylori infection.
Conclusion: Cation transport regulator 1 overexpression in H. pylori‐infected parietal 
cells may cause the H. pylori‐induced somatic mutations that contribute to the devel‐
opment of gastric cancer.
K E Y W O R D S
cation transport regulator 1, gastric cancer, Helicobacter pylori, parietal cells, secretary 
canaliculi
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1  | INTRODUC TION
Cation	transport	regulator	1	(CHAC1)	is	a	newly	discovered	enzyme	
involved in the γ‐glutamyl	cycle	that	can	degrade	glutathione	(GSH)	
into 5‐oxoproline and cysteinyl‐glycine.1,2	 CHAC1	 is	 a	 constituent	
of the unfolded protein response stress signaling pathway in the en‐
doplasmic	reticulum	(ER),3,4 and as a consequence of ER stress, the 
increase	in	CHAC1	leads	to	depletion	of	GSH	and	results	in	unbal‐
anced cellular redox levels.5
Endoplasmic reticulum stress is triggered by various stimuli, such 
as infection, inflammation, and gene mutations,6 and is widely re‐
lated to the development of several malignant tumors.7 Helicobacter 
pylori (H. pylori)	infection	can	mediate	ER	stress,8 drastically decreas‐
ing GSH levels and increasing the production of reactive oxygen 
species	(ROS)	in	gastric	epithelial	cells.9‐11 We recently reported that 
CHAC1	 expression	 is	 an	 essential	 factor	 driving	 these	 sequential	
changes in infected cells.12 The decreased GSH and increased ROS 
lead to somatic mutations in TP53, suggesting that H. pylori‐induced 
CHAC1	 overexpression	 in	 infected	 gastric	 epithelial	 cells	 directly	
contributes to gastric cancer.12
Helicobacter pylori is a gram‐negative, micro‐aerophilic spiral‐
shaped	bacterium	that	colonizes	the	gastric	mucosa	of	the	human	
stomach. More than half of the human population worldwide is 
infected with H. pylori.13	Immunohistochemistry	(IHC)	with	a	novel	
anti‐H. pylori	 monoclonal	 antibody	 (TMDU‐mAb)	 revealed	 that	
H. pylori can be detected not only in the mucus layer attached 
to the superficial gastric foveolar cells, but also in macrophages 
scattered in the lamina propria and notably in some parietal cells 
in H. pylori‐infected gastric mucosa.14 We recently reported that 
H. pylori	infection	promotes	CHAC1	expression,12 but the specific 
gastric cell types where this occurs in vivo in response to H. pylori 
infection were not clarified. In the present study, we examined 
gastric mucosa with or without H. pylori infection by real‐time re‐
verse	 transcription	 polymerase	 chain	 reaction	 (PCR)	 for	 CHAC1	
mRNA	 using	 fresh‐frozen	 tissues	 and	 by	 IHC	with	 a	 novel	 anti‐
CHAC1	 monoclonal	 antibody	 (CHAC1‐mAb(v1v2))	 to	 locate	 cells	
with	CHAC1	overexpression	in	formalin‐fixed	paraffin‐embedded	
(FFPE)	tissue	sections.
2  | MATERIAL S AND METHODS
2.1 | Human tissue samples
To	 investigate	 CHAC1	 expression	 in	 the	 gastric	 mucosa	 with	 or	
without H. pylori infection, we collected samples from patients with 
esophageal cancer that underwent esophago‐gastrectomy of the 
proximal one‐third of the stomach and lower half of the esophagus. 
This study was designed according to our previous result that H. py-
lori infection was detected by PCR or IHC in many samples from 
the corpus of the stomach with gastric cancer.14	Both	fresh‐frozen	
and 10% neutral buffered FFPE tissue samples of the gastric mu‐
cosa	were	 obtained	 from	 17	 patients	 with	H. pylori infection and 
24 patients without H. pylori infection between January 2013 and 
December	2016	at	Tokyo	Medical	and	Dental	University	Hospital.	
The fresh fundic‐gland mucosa was mounted in Tissue‐Tek OTC 
Compound	 (Sakura	 Finetek	 Japan),	 quick‐frozen	 in	 liquid	 nitrogen,	
and	maintained	−70°C	until	use.
The clinical profiles of the patients and H. pylori infection sta‐
tus of each sample are shown in Table S1. The H. pylori infection 
status	of	each	sample	was	estimated	by	enzyme	IHC	for	the	bacte‐
rium using FFPE tissue sections and real‐time PCR for the bacterial 
16S	 ribosomal	 RNA14	 using	 frozen	 sections.	 All	 patients	 received	
an explanation regarding the purpose of the study and provided 
written informed consent to participate in the study. The Tokyo 
Medical and Dental University ethics committee approved this study 
(Registration	No.	1706).	All	methods	were	performed	in	accordance	
with the relevant guidelines and regulations.
2.2 | DNA extraction and real‐time PCR
For	DNA	extraction,	60‐µm‐thick	fresh‐frozen	tissue	sections	were	
treated	with	TaKaRa	DEXPAT™	Easy	 (Takara	Bio	 Inc,)	according	 to	
the	manufacturer’s	 instructions.	Fragments	of	16S	 ribosomal	RNA	
of H. pylori were amplified by real‐time PCR using TaqMan Universal 
PCR	Master	Mix	 (ABgene).	 The	 primers	 and	 probes	 used	 for	 this	
assay	are	shown	in	Table	S2.	Amplification	and	detection	were	per‐
formed	using	the	ABI	PRISM	7900HT	Sequence	Detection	System	
(Applied	Biosystems).	The	amount	of	H. pylori	DNA	was	expressed	in	
terms of the number of bacterial genomes, with 1.25 × 1010 Da per 
genome	used	for	the	conversion.	Negative	controls	without	bacte‐
rial	DNA	were	included	in	every	PCR	assay;	background	values	were	
always <1 genome. Samples with one or more bacterial genome were 
considered positive. The total number of H. pylori in each sample was 
calculated by multiplying the assay results by 40.
2.3 | RNA extraction and real‐time reverse 
transcription‐PCR
To	extract	RNA,	60‐µm‐thick	fresh‐frozen	tissue	sections	were	treated	
with	1.0	mL	of	TRIzol®	reagent	(Invitrogen)	according	to	the	manufac‐
turer’s	instructions.	cDNA	was	synthesized	with	random	primers	using	
Superscript™	 Reverse	 Transcriptase	 (Invitrogen).	 The	 oligonucleotide	
primers	and	probes	are	listed	in	Table	S2.	The	relative	mRNA	quanti‐
fication was determined by real‐time reverse transcription‐PCR using 
the	TaqMan	Universal	PCR	Master	Mix	 (ABgene).	Amplification	and	
detection	 were	 performed	 with	 the	 ABI	 PRISM	 7900HT	 Sequence	
Detection	System	(Applied	Biosystems).	The	amount	of	target	cDNA	
was	 normalized	 with	 that	 of	 the	 endogenous	 mRNA	 of	 either	 the	
housekeeping reference β‐actin or the human proton pump/H,K‐
ATPase	α	subunit	for	fresh‐frozen	stomach	tissues.
2.4 | Enzyme Immunohistochemistry
Histologic	sections	(3‐µm‐thick)	cut	from	FFPE	tissue	samples	were	
mounted	 on	 silane‐coated	 slides	 (Muto	 Pure	 Chemicals	 Co.	 Ltd.),	
de‐paraffinized,	 rehydrated,	 and	 pretreated	 with	 the	 appropriate	
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antigen retrieval methods for each antigen. The sections were mi‐
crowaved	 for	40	minutes	at	97°C	 to	detect	CHAC1,	H. pylori, and 
proton	pump,	or	autoclaved	for	20	minutes	at	121°C	to	detect	the	
Ki67	antigen,	both	in	10	mM	citrate	buffer	(pH	6.0).	TMDU‐mAb	and	
CHAC1‐mAb(v1v2) are described elsewhere, respectively.
12,14 The 
proton	pump/H,K‐ATPase	α subunit, “proton pump,” is considered a 
specific marker of acid‐secreting parietal cells.15
Sections were treated with 3% hydrogen peroxide in methanol 
for 10 minutes, and then incubated with normal horse serum for 
10	minutes	(Vectastain	Universal	Elite	ABC	Kit;	Vector	Laboratories).	
The sections were then incubated with either of the appropriately 
diluted	first	antibodies	(CHAC1‐mAb(v1v2),	TMDU‐mAb,	anti‐proton	
pump	 antibody	 [D031,	MBL],	 or	 Ki‐67	 antibody	 [M7240,	 DAKO])	
overnight at room temperature. Following incubation with bioti‐
nylated horse secondary antibody, the sections were incubated 
with streptavidin‐peroxidase complex for 30 minutes at room 
temperature	(Vectastain	Universal	Elite	ABC	Kit).	Before	and	after	
each	 step,	 the	 sections	 were	 washed	 with	 PBS	 containing	 0.25%	
Tween‐20.	Diaminobenzidine	 (Histofine	Simplestain	DAB	Solution;	
Nichirei	Bioscience)	was	used	as	the	chromogen.	All	specimens	were	
counterstained	with	Mayer’s	 hematoxylin.	Adjacent	 sections	were	
stained with hematoxylin and eosin staining for further histologic 
examination.
2.5 | Double‐enzyme and fluorescence 
Immunohistochemistry
Histologic sections were processed in the same manner as for en‐
zyme	 IHC	up	 to	 the	primary	 antibody	 reaction.	The	 sections	were	
incubated with alkaline phosphatase‐conjugated secondary antibody 
followed	by	the	VECTOR	Blue	Alkaline	Phosphatase	Substrate	Kit	III	
(SK‐5300,	Vector	Laboratories)	or	with	biotinylated	horse	secondary	
antibody	 (Vectastain	 Universal	 Elite	 ABC	 Kit),	 and	 then	 incubated	
with fluorescein isothiocyanate‐conjugated streptavidin (F0250, 
DAKO).	 The	 sections	were	 then	microwaved	 in	 10	mmol/L	 citrate	
buffer	(pH	6.0)	for	20	minutes	to	inactivate	the	antibodies	used	for	
detecting the first antigen, and then incubated with normal horse 
serum for 10 minutes. Subsequently, the sections were incubated 
overnight with the appropriately diluted first antibodies against the 
second antigen at room temperature. The sections were next incu‐
bated	with	EnVision	+	System‐HRP	Labelled	Polymer	(K4001,	DAKO)	
followed	by	 the	Histofine	Simplestain	DAB	Solution,	or	with	 tetra‐
methylrhodamine isothiocyanate‐conjugated anti‐mouse immuno‐
globulin	 (R0270,	DAKO).	Double	 fluorescence	 IHC	was	 performed	
using	a	fluorescence	laser‐scanning	microscope	(FV1200;	Olympus).
2.6 | Immuno‐electron microscopy
Histologic sections were processed in the same manner as for IHC 
until the signal development against H. pylori	by	DAB.	The	sections	
were	washed	several	times	with	0.1	mol/L	phosphate	buffer	(pH	7.4),	
and	fixed	with	2.5%	glutaraldehyde	 in	0.1	mol/L	phosphate	buffer	
for	 60	minutes	 at	 4°C,	 followed	by	 post‐fixation	with	1%	osmium	
tetroxide	 for	60	minutes	 at	 room	 temperature.	The	 sections	were	
then	 dehydrated	 and	 embedded	 in	 Epon	 812	 (TAAB	 Laboratories	
Equipment	 Ltd.,).	 For	 flat	 embedded	 specimens,	 gelatin	 capsules	
filled with Epon were placed on top of section areas that were se‐
lected	 based	 on	 parallel	 sections	 treated	 for	 enzyme	 IHC.	 After	
polymerization,	the	Epon	blocks	containing	the	tissue	were	peeled	
from the glass slides by heating, and trimmed precisely with small 
tissue areas (1 mm2)	readily	identifiable	on	the	block	surface	under	
reflective	light.	A	Reichert	Ultracut	S	(Leica	EM	UC7	Microsystems,	
Heidelberg	 GmbH)	 was	 used	 to	 cut	 ultrathin	 sections	 that	 were	
collected	on	Maxtaform	grids	 (Pyser‐SGL	Ltd.,).	The	sections	were	
stained with uranium and lead citrate and examined under an 
H‐7700	electron	microscope	(Hitachi	High‐Technologies	Co.,).
2.7 | Statistical analysis
Statistical	 analysis	 was	 performed	 using	 GraphPad	 PRISM	 ver.	 6	
(GraphPad	 Software,	 Inc,).	 Differences	 in	 the	 CHAC1	 mRNA	 ex‐
pression between samples with and without H. pylori infection were 
assessed using the Mann‐Whitney U	 test.	A	 two‐tailed	P‐value of 
<0.05 was considered statistically significant.
F I G U R E  1  Representative	images	of	CHAC1	IHC	in	gastric	
mucosa with or without Helicobacter pylori	infection.	(A)	Weak	
positive	signals	of	CHAC1	IHC	(brown	staining,	see	inset)	are	
observed in the fundic‐gland mucosa without H. pylori	infection.	(B)	
Strong	positive	signals	(see	inset)	and	other	weak	positive	signals	
(see	inset)	of	CHAC1	IHC	are	observed	in	the	fundic‐gland	mucosa	
with H. pylori	infection.	Bars:	200	µm
(A)
(B)
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3  | RESULTS
3.1 | Cation transport regulator 1 expression in 
Helicobacter pylori‐infected gastric mucosa
Immunohistochemistry	with	the	CHAC1‐mAb(v1v2) revealed weak 
CHAC1	expression,	ranging	from	a	few	to	many	cells,	in	the	fun‐
dic‐gland areas of gastric mucosa with or without H. pylori infec‐
tion	 (Figure	1A).	 Strong	CHAC1	expression	 in	 a	 varying	number	
of cells was observed in the fundic‐glands of gastric mucosa with 
H. pylori	 infection	 (Figure	 1B).	 Fundic‐gland	 cells	 with	 transient	
density between the strong and weak signals developed by IHC 
were not infrequently observed in many samples with H. pylori in‐
fection	and	a	 few	samples	without	 the	 infection.	CHAC1	mRNA	
expression was detected in all fresh gastric tissue samples, ex‐
cept for two samples without H. pylori	 infection.	When	CHAC1	
mRNA	expression	 in	 the	 fresh	 stomach	samples	was	normalized	
to that of the housekeeping reference β‐actin gene, we observed 
no	 significant	 differences	 in	 relative	 CHAC1	 mRNA	 expression	
between samples with and without H. pylori	infection	(Figure	2A).	
Considering	the	specific	localization	of	strong	CHAC1	expression	
in the parietal cells observed by IHC shown in Figure 1, we nor‐
malized	 CHAC1	mRNA	 expression	 to	 the	 human	 proton	 pump/
H,K‐ATPase	 α	 subunit	 (proton	 pump)	 mRNA	 expression,	 which	
is specifically expressed in parietal cells. This analysis revealed a 
significant	difference	in	CHAC1	mRNA	expression	between	sam‐
ples with and without H. pylori	infection:	Significant	CHAC1	over‐
expression	 (ratio	 ranging	 from	 0.8	 to	 2.6)	 was	 detected	 in	 6	 of	
17	samples	 (35%)	with	H. pylori infection and in 0 of 24 samples 
without H. pylori	infection	(Figure	2B).	Excluding	the	six	infected	
samples	with	significant	CHAC1	overexpression	and	the	two	un‐
infected	samples	with	no	CHAC1	expression	detected,	a	constitu‐
tively	low	level	of	CHAC1	expression	(ratio	ranging	from	0.001	to	
0.1)	was	observed	in	all	samples	regardless	of	the	H. pylori infec‐
tion	 status,	 reflecting	 the	weak	CHAC1	 expression	 detected	 by	
IHC in the fundic‐gland areas of gastric mucosa with and without 
H. pylori	infection	(Figure	1).
3.2 | Localization of CHAC1 overexpression in 
Helicobacter pylori‐infected gastric mucosa
As	CHAC1	seemed	to	be	overexpressed	in	specific	cells	of	the	gastric	
mucosa with H. pylori	infection,	double‐enzyme	or	fluorescence	IHC	
with each combination of two of the anti‐H. pylori, anti‐proton pump, 
and	anti‐CHAC1	antibodies	was	performed	using	serial	sections	of	
the H. pylori‐infected stomach samples. H. pylori was detected in 
some of the parietal cells positive for expression of the proton pump 
(Figure	3A	and	3).	Strong	CHAC1	expression	was	detected	in	some	
of	these	proton	pump‐positive	parietal	cells	(Figure	3C	and	3).	Strong	
CHAC1	overexpression	was	also	observed	in	many	H. pylori‐infected 
parietal	cells	(Figure	3E	and	3).	Taken	together,	these	observations	
indicated	that	CHAC1	overexpression	was	 localized	 in	H. pylori‐in‐
fected parietal cells of the human gastric mucosa.
3.3 | Immuno‐electron microscopy observation of 
Helicobacter pylori in parietal cells
Although	H. pylori is generally considered a noninvasive extracellular 
bacterium, many immunoreactive signals were detected inside some 
parietal cells in many samples with H. pylori infection. Therefore, we 
used	immuno‐electron	microscopy	to	further	examine	the	localiza‐
tion of H. pylori	in	the	gastric	mucosa	(Figure	4A	and	B,	and	Figure	5A	
and	 5).	 Helicobacter pylori staining in the mucous layer revealed 
dense rim staining of a whole H. pylori organism, consistent with 
the	assumed	distribution	of	 lipopolysaccharides	 (Figure	4C).	 In	ad‐
dition, some bacterial cells that had the same staining patterns were 
located	 in	 the	secretory	canaliculi	of	 the	parietal	cells	 (Figure	5C).	
Higher magnification confirmed that the H. pylori cells embedded in 
the	secretory	canaliculi	were	intact	(Figure	5D	and	5).
3.4 | Evidence of proliferation found in some 
parietal lineage cells
Helicobacter pylori infection contributes to the progression of gas‐
tric cancer.16‐18 Helicobacter pylori infection induces changes to the 
gastric mucosa and increases cell proliferation, which can eventually 
lead to inflammation‐associated oncogenesis.19 We examined the 
extent of parietal cell proliferation in H. pylori‐infected samples using 
double‐enzyme	IHC	with	anti‐Ki67	antibody	to	detect	proliferation	
and an anti‐proton pump antibody to identify parietal cells. These 
studies indicated that some parietal cells exhibited positive nuclear 
signals	for	Ki67	in	the	neck	zone	of	the	gastric	fundic‐gland	mucosa	
with H. pylori	infection	(Figure	6).
4  | DISCUSSION
Cation transport regulator 1 is a novel ER stress‐inducible gene, 
and	in	the	presence	of	ER	stress,	CHAC1	mRNA	levels	are	upregu‐
lated.3,4 Infection is a factor that stimulates ER stress,20‐22 and our 
previous in vitro study demonstrated that H. pylori‐triggered ER 
stress	 led	 to	 the	overproduction	of	CHAC1.12 To date, there have 
been	no	IHC	studies	of	CHAC1	expression	in	human	tissues	because	
F I G U R E  2  CHAC1	mRNA	expression	in	gastric	mucosa	with	or	
without Helicobacter pylori	infection.	(A)	CHAC1	mRNA	expression	
in	fresh	gastric	mucosa	samples	normalized	with	that	of	β‐actin. 
(B)	CHAC1	mRNA	expression	in	the	same	samples	normalized	with	
that of the proton pump. *Mann‐Whitney U	test.	NS:	not	significant
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commercially	 available	 anti‐CHAC1	 antibodies	 cannot	 be	 used	 in	
FFPE	 samples.	Using	a	novel	 antibody	against	CHAC1,12 however, 
we	demonstrated	in	situ	CHAC1	expression	in	human	stomach	FFPE	
samples.	CHAC1	expression	was	observed	as	weakly	stained	posi‐
tive signals in fundic‐gland areas of the gastric mucosa irrespective 
of the H. pylori infection status. In contrast, H. pylori‐infected sam‐
ples	showed	strongly	stained	CHAC1‐positive	signals	 in	some	fun‐
dic‐gland	cells.	Colocalization	of	proton	pump	signals	with	CHAC1	
expression suggests that H. pylori infection is specifically associated 
with	 CHAC1	 overexpression	 in	 the	 parietal	 cells	 in	 the	 stomach.	
These findings confirmed in vivo the previously reported associa‐
tion between H. pylori	infection	and	the	strong	induction	of	CHAC1.	
This confirmation suggests that, in contrast to the low‐level consti‐
tutive	 expression	 of	 CHAC1	 observed	 in	many	 fundic‐gland	 cells,	
high	levels	of	CHAC1	overexpression	observed	in	some	parietal	cells	
are likely to induce the remarkable changes in the cellular redox bal‐
ance and increase in TP53 mutations12 that are associated with the 
CHAC1	overexpression	induced	by	H. pylori infection in vitro.
F I G U R E  3  CHAC1	overexpression	in	proton	pump/H,K‐ATPase	α	subunit	(PUMP)‐positive	parietal	cells	with	Helicobacter.pylori	(HP)	
infection.	Double‐enzyme	or	fluorescence	IHC	for	an	identical	sample	of	H. pylori‐infected fundic‐gland mucosa from a subject with chronic 
atrophic gastritis. H. pylori	is	located	in	the	proton	pump‐positive	cells	(arrows),	(A	and	B)	with	anti‐proton	pump	antibody	blue	or	green	and	
TMDU‐mAb	(anti‐H. pylori)	brown	or	red.	CHAC1	is	overexpressed	in	the	proton	pump‐positive	cells	(arrows)	(C	and	D)	with	CHAC1‐mAb	
blue	or	green	and	anti‐proton	pump	antibody	brown	or	red.	CHAC1	is	overexpressed	in	parietal	cells	with	H. pylori	infection	(arrows)	(E	and	
F)	with	CHAC1‐mAb	blue	or	green	and	TMDU‐mAb	brown	or	red.	Bars:	50	µm
(A) (B)
(C) (D)
(E) (F)
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The	 TMDU‐mAb	 used	 in	 this	 study	 has	 higher	 sensitivity	 for	
detecting H. pylori in FFPE samples of the human stomach than 
commercially available anti‐H. pylori antibody products, such as the 
polyclonal	antibody	from	DAKO	(B0471)	and	the	monoclonal	anti‐
body	 from	CHEMICON	 (MAB922),	 as	 described	 previously.14 IHC 
with	TMDU‐mAb	can	detect	H. pylori not only in the mucous layer, 
but also in macrophages and parietal cells of H. pylori‐infected gas‐
tric	mucosa.	Notably,	double‐enzyme	IHC	revealed	no	CHAC1	over‐
expression in gastric foveolar epithelial cells, even in cells with many 
H. pylori	attached	to	the	surface.	In	contrast,	CHAC1	overexpression	
was observed by IHC in parietal cells of the H. pylori‐infected stom‐
ach,	 including	all	cases	with	significant	CHAC1	mRNA	overexpres‐
sion.	To	investigate	the	localization	of	H. pylori in parietal cells, we 
performed immuno‐electron microscopy. In H. pylori‐infected gastric 
mucosa, bacterial cells were not observed in the cytoplasmic space, 
but in the secretory canaliculi of the parietal cells. These bacteria 
were morphologically similar to those observed in the mucous layer 
and, based on their rim staining, the immunoreactive bacterial cells 
appear to remain intact. This is consistent with the lipopolysaccha‐
ride distribution of whole H. pylori organisms in the mucous layer.14 
Helicobacter pylori infection affects epithelial cells at an early stage 
when a large number of H. pylori cells are present,16 whereas the di‐
rect actions of H. pylori on epithelial cells seem to be less important 
at the late stage when the H. pylori cells appear to decrease in num‐
ber or even disappear altogether with the progression of atrophic 
gastritis in association with the development of intestinal metapla‐
sia.16 The present findings suggest that stable H. pylori	colonization	
in the secretory canaliculi of parietal cells, rather than the presence 
of unstably attached H. pylori to foveolar epithelial cells, may be nec‐
essary	to	 induce	CHAC1	overexpression.	The	reason	why	H. pylori 
can live in the secretory canaliculus of the parietal cell, where the 
pH is extremely low,23 may be associated with H. pylori‐mediated re‐
pression	of	the	proton	pump,	the	parietal	cell	enzyme	mediating	acid	
secretion, and ensuing hypochlorhydria in the secretory canaliculus 
of the infected parietal cell.24
Previous	in	vitro	experiments	identified	CHAC1	overexpression	
as a risk factor for the induction of nucleotide alterations in the TP53 
tumor suppressor gene resulting from cellular oxidative stress, which 
initially	arises	from	the	depletion	of	intracellular	GSH	by	CHAC1	and	
the accumulation of ROS.9‐12,25,26 Thus, stable H. pylori	 coloniza‐
tion in the secretory canaliculi of parietal cells may lead to constant 
CHAC1	overexpression	in	those	cells,	resulting	in	genetic	mutations	
that	are	more	likely	to	contribute	to	gastric	carcinogenesis.	Because	
it	has	not	been	feasible	to	evaluate	CHAC1	activity	in	histologic	sam‐
ples,	 further	understanding	of	 the	CHAC1	function	 in	specific	cell	
types will depend on future technical developments.
Helicobacter pylori infection is a leading factor in the develop‐
ment of gastric carcinoma.16‐18 During H. pylori infection, several 
alterations occur in the gastric mucosa, including cell proliferation, 
and these changes eventually lead to inflammation‐associated onco‐
genesis.19 TP53	mutations	 induced	by	CHAC1	overexpression	may	
be more likely to contribute to gastric carcinogenesis in the parietal 
cells	of	the	gastric	neck	zone	with	a	long	cell	cycle	(54	days)	than	in	
the	foveolar	epithelial	cells	of	the	gastric‐pit	zone	with	a	short	cell	
cycle	(3	days).27 Stem cells of the gastric mucosa give rise to the com‐
mitted	progenitors	of	parietal	cells	(pre‐parietal	cells),	either	directly	
or indirectly.28 Indeed, in the present study, some proton pump‐pos‐
itive cells of parietal cell lineage were in the process of cell prolifer‐
ation	as	indicated	by	positive	Ki67	staining.	Thus,	H. pylori‐infected 
parietal cells with the potential for survival and proliferation may be 
key contributors to the development of gastric cancer.
Gastric adenocarcinoma is a heterogeneous disease com‐
monly classified into two main histologic types, intestinal and dif‐
fuse.29 Helicobacter infection is a major risk factor for both types.30 
Helicobacter pylori infection is associated with the development of 
diffuse‐type gastric cancer,31,32 which is thought to develop directly 
from chronic gastritis without intestinal metaplasia, whereas intes‐
tinal‐type gastric cancer is thought to develop from atrophic gastri‐
tis with intestinal metaplasia.33‐35 Gastric cancer arising specifically 
from parietal cells has not been extensively investigated. Shimada 
F I G U R E  4  Localization	of	Helicobacter pylori cells in mucous layer attached to gastric foveolar epithelial cells. Serial histologic sections 
of a sample with prominent H. pylori	infection	were	used	for	hematoxylin	&	eosin	staining	(A)	and	IHC	with	TMDU‐mAb	(B)	followed	by	
immuno‐electron	microscopy	(C).	(A	and	B)	show	an	identical	area	of	the	H. pylori‐infected gastric mucosa. The area with immunoreactive 
H. pylori	indicated	by	an	arrow	in	b	was	subjected	to	immuno‐electron	microscopy.	(c)	Several	H. pylori organisms with a dense rim‐staining 
pattern	indicated	by	arrows	were	observed	on	the	foveolar	epithelial	cell.	Bars:	20	µm	(A	and	B),	1.0	µm	(C)
(A) (B) (C)
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F I G U R E  5  Localization	of	Helicobacter pylori cells in secretory canaliculi of the infected parietal cells. Serial histologic sections of 
a sample with prominent H. pylori	infection	in	parietal	cells	were	used	for	(A)	hematoxylin	&	eosin	staining;	(B)	IHC	with	TMDU‐mAb	
(anti‐H. pylori);	followed	by	(C)	immuno‐electron	microscopy.	In	b	an	arrow	indicates	H. pylori	colonization	and	an	inset	shows	higher	
magnification	of	the	bacteria	indicated	by	the	arrow.	(C)	H. pylori	colonization	was	observed	in	the	secretory	canaliculi	of	the	parietal	cells	
and	is	located	near	the	entry	(a	short	arrow)	and	in	a	deeper	area	(long	arrow).	(D	and	E)	respectively	show	higher	magnification	of	the	
H. pylori	cells	indicated	in	c	by	a	short	or	long	arrow.	Note	the	intact	and	not	denatured	bacterial	cells	with	a	dense	rim‐staining	pattern	
corresponding	to	the	distribution	of	the	bacterial	cell	membrane‐bound	lipopolysaccharide	detected	by	the	antibody.	Bars:	50	µm	(A	and	B),	
5.0	µm	(C)	and	1.0	µm	(D	and	E)
(A)
(C)
(D) (E)
(B)
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et al15 reported diffuse‐type gastric cancer in all double‐conditional 
knockout mice in which E‐cadherin and p53 were specifically inacti‐
vated	in	the	gastric	parietal	cell	lineage.	Thus,	DNA	damage	to	these	
genes	by	CHAC1‐induced	oxidative	stress	in	the	gastric	parietal	cell	
lineage is a potential mechanism leading to the development of dif‐
fuse‐type gastric cancer in patients with H. pylori infection.
In	 conclusion,	 CHAC1	 overexpression	 was	 induced	 in	 parietal	
cells of the gastric mucosa where H. pylori	stably	colonized	in	their	
secretory canaliculi. Taken together with the results from our previ‐
ous study in vitro,12 H. pylori‐induced	CHAC1	overexpression	in	pari‐
etal cells may cause somatic mutations that further contribute to the 
development of gastric cancer.
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